HSIC
57
4
DAL
64
2
NRG
40
3
MAT
43
2
ALL
37
-3
AAP
35
-6
EMC
77
6
PRU
47
-4
SJM
21
-3
SLB
42
3
SYF
86
3
RHI
59
2
MDLZ
36
2
NKE
42
6
CMI
58
-2
LEN
46
-3
DLTR
51
-3
CINF
31
2
ITW
58
-4
GOOGL
72
5
HSIC
57
4
DAL
64
2
NRG
40
3
MAT
43
2
ALL
37
-3
AAP
35
-6
EMC
77
6
PRU
47
-4
SJM
21
-3
SLB
42
3
SYF
86
3
RHI
59
2
MDLZ
36
2
NKE
42
6
CMI
58
-2
LEN
46
-3
DLTR
51
-3
CINF
31
2
ITW
58
-4
GOOGL
72
5
Financhill
Back

RaySearch Laboratories AB 10K Form

Buy
83

RSLBF
RaySearch Laboratories AB

Last Price:
19.09
Seasonality Move:
2.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RSLBF News And Ratings

See the #1 stock for the next 7 days that we like better than RSLBF

RSLBF Financial Statistics

Sales & Book Value

Annual Sales: $96.55M
Cash Flow: $2.69M
Price / Cash Flow: 24.33
Annual Sales: $2.35
Price / Book: 8.14

Profitability

EPS (TTM): 0.48480
Net Income (TTM): $16.64M
Gross Margin: $86.48M
Return on Equity: 22.88%
Return on Assets: 8.73%

RaySearch Laboratories AB Earnings Forecast

Key RaySearch Laboratories AB Financial Ratios

  • The Gross Profit Margin over the past 21 years for RSLBF is 89.57%.
  • The Selling, General & Administrative Expenses for RSLBF have been equal to 54.59% of Gross Profit Margin.
  • The Research & Development expenses have been 23.26% of Revenue.
  • The Interest Expense is 11.88% of Operating Income.
  • The Net Earning history of RSLBF is 7.98% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 10 years.

RaySearch Laboratories AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Technology
Sector: Health Care
Current Symbol: RSLBF
Website: raysearchlabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.3
Quick Ratio: 1.27

Price-to-Earnings

Trailing P/E Ratio: 84.94
Forward P/E Ratio: 0

RSLBF Technical Analysis vs Fundamental Analysis

Buy
83
RaySearch Laboratories AB (RSLBF) is a Buy

Is RaySearch Laboratories AB a Buy or a Sell?